Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 26 | 2023 | 3200 | 2.240 |
Why?
|
Kidney Neoplasms | 25 | 2023 | 4300 | 1.960 |
Why?
|
Diagnostic Imaging | 33 | 2019 | 3538 | 1.710 |
Why?
|
Molecular Targeted Therapy | 24 | 2018 | 2830 | 1.650 |
Why?
|
Neoplasm Metastasis | 18 | 2019 | 4926 | 0.810 |
Why?
|
Tomography, X-Ray Computed | 41 | 2023 | 20776 | 0.800 |
Why?
|
Angiogenesis Inhibitors | 8 | 2017 | 2059 | 0.790 |
Why?
|
Radiology | 9 | 2022 | 2104 | 0.780 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2018 | 3518 | 0.770 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 131 | 0.610 |
Why?
|
Muscle Neoplasms | 1 | 2017 | 130 | 0.540 |
Why?
|
Gastrointestinal Stromal Tumors | 8 | 2015 | 617 | 0.530 |
Why?
|
Neoplasms | 19 | 2017 | 22389 | 0.500 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 308 | 0.460 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2017 | 2251 | 0.450 |
Why?
|
Gastrointestinal Neoplasms | 7 | 2015 | 957 | 0.440 |
Why?
|
Soft Tissue Neoplasms | 5 | 2015 | 1166 | 0.420 |
Why?
|
Antineoplastic Agents | 18 | 2018 | 13698 | 0.410 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3629 | 0.410 |
Why?
|
Medical Oncology | 3 | 2019 | 2350 | 0.390 |
Why?
|
Vinblastine | 2 | 2014 | 487 | 0.370 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.360 |
Why?
|
Positron-Emission Tomography | 18 | 2016 | 6673 | 0.360 |
Why?
|
Charcot-Marie-Tooth Disease | 4 | 2008 | 102 | 0.360 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 2422 | 0.350 |
Why?
|
Urothelium | 1 | 2011 | 276 | 0.330 |
Why?
|
Neoplasm Staging | 15 | 2018 | 11262 | 0.330 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2014 | 799 | 0.310 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1134 | 0.310 |
Why?
|
Thromboembolism | 1 | 2014 | 1004 | 0.300 |
Why?
|
Colonic Diseases | 1 | 2009 | 204 | 0.300 |
Why?
|
Oncology Service, Hospital | 3 | 2017 | 57 | 0.290 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9264 | 0.290 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1642 | 0.270 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2016 | 2044 | 0.270 |
Why?
|
Radiopharmaceuticals | 11 | 2015 | 2734 | 0.270 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2015 | 2056 | 0.260 |
Why?
|
Benzamides | 5 | 2015 | 1387 | 0.260 |
Why?
|
Endosonography | 2 | 2015 | 626 | 0.260 |
Why?
|
Humans | 122 | 2023 | 768970 | 0.250 |
Why?
|
Bone Neoplasms | 6 | 2018 | 2565 | 0.250 |
Why?
|
Vascular Diseases | 1 | 2014 | 1163 | 0.250 |
Why?
|
Curriculum | 2 | 2017 | 3782 | 0.250 |
Why?
|
Liver Diseases | 1 | 2014 | 1305 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 21 | 2017 | 36854 | 0.240 |
Why?
|
Tumor Burden | 1 | 2011 | 1913 | 0.240 |
Why?
|
Skin Neoplasms | 4 | 2021 | 5864 | 0.230 |
Why?
|
Genomics | 2 | 2019 | 5928 | 0.220 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2016 | 2063 | 0.220 |
Why?
|
Sarcoma | 5 | 2016 | 1806 | 0.210 |
Why?
|
Diagnosis, Differential | 17 | 2017 | 13021 | 0.210 |
Why?
|
Liver Neoplasms | 7 | 2017 | 4363 | 0.210 |
Why?
|
Fibromatosis, Aggressive | 2 | 2016 | 125 | 0.210 |
Why?
|
Treatment Outcome | 26 | 2018 | 65480 | 0.210 |
Why?
|
Hemorrhage | 1 | 2014 | 3466 | 0.200 |
Why?
|
Ultrasonography | 3 | 2014 | 6002 | 0.200 |
Why?
|
Pyrimidines | 7 | 2018 | 3048 | 0.190 |
Why?
|
Neuroendocrine Tumors | 3 | 2018 | 657 | 0.190 |
Why?
|
Piperazines | 5 | 2015 | 2553 | 0.190 |
Why?
|
Aged | 49 | 2021 | 171786 | 0.180 |
Why?
|
Thrombosis | 1 | 2015 | 2956 | 0.180 |
Why?
|
Pyrroles | 3 | 2013 | 1125 | 0.180 |
Why?
|
Aged, 80 and over | 27 | 2021 | 59739 | 0.180 |
Why?
|
Middle Aged | 51 | 2021 | 223737 | 0.180 |
Why?
|
von Hippel-Lindau Disease | 1 | 2021 | 154 | 0.170 |
Why?
|
Hematologic Neoplasms | 5 | 2016 | 1907 | 0.170 |
Why?
|
ROC Curve | 3 | 2014 | 3629 | 0.170 |
Why?
|
Lymphoma | 4 | 2014 | 1900 | 0.170 |
Why?
|
Niacinamide | 2 | 2013 | 418 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2018 | 5707 | 0.170 |
Why?
|
Teratoma | 2 | 2014 | 405 | 0.170 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1183 | 0.170 |
Why?
|
Carcinoid Tumor | 1 | 2021 | 224 | 0.170 |
Why?
|
Female | 62 | 2022 | 397515 | 0.160 |
Why?
|
Male | 61 | 2022 | 365203 | 0.160 |
Why?
|
Esophageal Neoplasms | 3 | 2015 | 1674 | 0.160 |
Why?
|
Phenylurea Compounds | 2 | 2013 | 531 | 0.160 |
Why?
|
Observer Variation | 4 | 2013 | 2623 | 0.160 |
Why?
|
Indoles | 3 | 2013 | 1836 | 0.160 |
Why?
|
Edema | 4 | 2015 | 766 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2016 | 9442 | 0.150 |
Why?
|
Urogenital Neoplasms | 1 | 2019 | 132 | 0.150 |
Why?
|
Contrast Media | 14 | 2017 | 5334 | 0.150 |
Why?
|
Radium | 1 | 2018 | 70 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2015 | 4064 | 0.140 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2017 | 29 | 0.140 |
Why?
|
Adenoma, Liver Cell | 1 | 2017 | 32 | 0.140 |
Why?
|
Adult | 40 | 2021 | 223851 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2012 | 735 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5342 | 0.130 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 53 | 0.130 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 2182 | 0.130 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 159 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6856 | 0.130 |
Why?
|
Pneumatosis Cystoides Intestinalis | 2 | 2012 | 31 | 0.130 |
Why?
|
Pancreatitis | 2 | 2013 | 1087 | 0.130 |
Why?
|
Kidney | 1 | 2011 | 7058 | 0.130 |
Why?
|
Nerve Degeneration | 1 | 2000 | 750 | 0.130 |
Why?
|
Intestinal Fistula | 2 | 2013 | 144 | 0.130 |
Why?
|
Osteosarcoma | 2 | 2012 | 911 | 0.130 |
Why?
|
Prognosis | 13 | 2017 | 30046 | 0.120 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2017 | 125 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 2336 | 0.120 |
Why?
|
Hormone Antagonists | 1 | 2015 | 108 | 0.120 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 168 | 0.120 |
Why?
|
Cholecystitis | 2 | 2013 | 181 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 353 | 0.120 |
Why?
|
Retrospective Studies | 22 | 2022 | 81903 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 210 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.110 |
Why?
|
Neural Conduction | 3 | 2008 | 443 | 0.110 |
Why?
|
Intestinal Perforation | 2 | 2012 | 254 | 0.110 |
Why?
|
Neoadjuvant Therapy | 3 | 2014 | 2909 | 0.110 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2015 | 234 | 0.110 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2848 | 0.110 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5443 | 0.110 |
Why?
|
Vena Cava, Inferior | 2 | 2017 | 463 | 0.110 |
Why?
|
Protective Agents | 1 | 2014 | 151 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1887 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2784 | 0.100 |
Why?
|
Peripheral Nerves | 2 | 2008 | 492 | 0.100 |
Why?
|
Rhabdomyoma | 1 | 2012 | 56 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 139 | 0.100 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 52 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 6547 | 0.100 |
Why?
|
Histiocytic Sarcoma | 1 | 2012 | 40 | 0.100 |
Why?
|
Axons | 1 | 2000 | 1678 | 0.100 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2013 | 101 | 0.100 |
Why?
|
Intestine, Small | 2 | 2015 | 1218 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 409 | 0.100 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2011 | 43 | 0.100 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.090 |
Why?
|
Histiocytosis, Sinus | 1 | 2011 | 44 | 0.090 |
Why?
|
Splenic Neoplasms | 1 | 2011 | 97 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 631 | 0.090 |
Why?
|
Hormones | 1 | 2015 | 870 | 0.090 |
Why?
|
Problem Solving | 1 | 2014 | 443 | 0.090 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 170 | 0.090 |
Why?
|
Hepatitis | 1 | 2013 | 228 | 0.090 |
Why?
|
Sarcoma, Synovial | 1 | 2012 | 156 | 0.090 |
Why?
|
Vulvar Neoplasms | 1 | 2013 | 266 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
Veins | 1 | 2015 | 769 | 0.090 |
Why?
|
Radiography | 7 | 2015 | 6991 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 793 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 926 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2018 | 11886 | 0.090 |
Why?
|
Benzenesulfonates | 1 | 2011 | 170 | 0.090 |
Why?
|
Thoracic Wall | 1 | 2012 | 204 | 0.090 |
Why?
|
Peritoneal Neoplasms | 2 | 2015 | 714 | 0.090 |
Why?
|
Pheochromocytoma | 1 | 2012 | 328 | 0.080 |
Why?
|
Sacrum | 1 | 2011 | 275 | 0.080 |
Why?
|
Thoracic Neoplasms | 1 | 2012 | 269 | 0.080 |
Why?
|
Pathology, Molecular | 1 | 2013 | 329 | 0.080 |
Why?
|
Lymphocytes | 1 | 2018 | 2614 | 0.080 |
Why?
|
Rhabdomyosarcoma | 1 | 2012 | 358 | 0.080 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13594 | 0.080 |
Why?
|
Enteritis | 1 | 2011 | 164 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6401 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 304 | 0.080 |
Why?
|
Anus Neoplasms | 1 | 2013 | 336 | 0.080 |
Why?
|
Cystectomy | 1 | 2014 | 645 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 565 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2011 | 419 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 965 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 541 | 0.080 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2012 | 335 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 496 | 0.080 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2013 | 329 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 840 | 0.080 |
Why?
|
Chordoma | 1 | 2011 | 349 | 0.080 |
Why?
|
Liposarcoma | 1 | 2011 | 289 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.080 |
Why?
|
Electrodiagnosis | 2 | 2008 | 149 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 527 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5716 | 0.070 |
Why?
|
Melanoma | 3 | 2017 | 5709 | 0.070 |
Why?
|
Testicular Neoplasms | 1 | 2014 | 808 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 954 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1560 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2012 | 505 | 0.070 |
Why?
|
Urologic Neoplasms | 1 | 2011 | 318 | 0.070 |
Why?
|
Colitis | 2 | 2013 | 1242 | 0.070 |
Why?
|
Spinal Neoplasms | 1 | 2014 | 715 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 561 | 0.070 |
Why?
|
Sirolimus | 2 | 2012 | 1540 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 592 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 930 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1535 | 0.070 |
Why?
|
Internship and Residency | 1 | 2007 | 5956 | 0.070 |
Why?
|
Gait Disorders, Neurologic | 1 | 2009 | 243 | 0.070 |
Why?
|
Image Enhancement | 2 | 2017 | 2898 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1483 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3411 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2013 | 20245 | 0.060 |
Why?
|
Lymphatic Metastasis | 4 | 2015 | 2916 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2812 | 0.060 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 562 | 0.060 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 615 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2012 | 957 | 0.060 |
Why?
|
Decision Trees | 2 | 2017 | 509 | 0.060 |
Why?
|
Connexins | 1 | 2007 | 355 | 0.060 |
Why?
|
Pyridines | 2 | 2021 | 2895 | 0.060 |
Why?
|
Neutrophils | 1 | 2018 | 3785 | 0.060 |
Why?
|
Survival Analysis | 4 | 2019 | 10115 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2014 | 3554 | 0.060 |
Why?
|
Amyloidosis | 1 | 2012 | 879 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5544 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 639 | 0.060 |
Why?
|
Indazoles | 2 | 2018 | 306 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3628 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15471 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1386 | 0.050 |
Why?
|
Education, Medical | 1 | 2015 | 1742 | 0.050 |
Why?
|
Ascites | 2 | 2015 | 338 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2012 | 1424 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40261 | 0.050 |
Why?
|
Pericardial Effusion | 2 | 2015 | 246 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2360 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1756 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14201 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2021 | 9213 | 0.050 |
Why?
|
Boston | 2 | 2016 | 9377 | 0.050 |
Why?
|
Pleural Effusion | 2 | 2015 | 345 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14752 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2340 | 0.050 |
Why?
|
Disability Evaluation | 2 | 2008 | 1839 | 0.050 |
Why?
|
Action Potentials | 3 | 2008 | 1838 | 0.050 |
Why?
|
Phenotype | 3 | 2021 | 16731 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 18068 | 0.040 |
Why?
|
Gene Silencing | 1 | 2007 | 1505 | 0.040 |
Why?
|
Pneumonia | 1 | 2012 | 2164 | 0.040 |
Why?
|
Isometric Contraction | 1 | 2000 | 150 | 0.040 |
Why?
|
Urogenital System | 1 | 2019 | 88 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 610 | 0.040 |
Why?
|
Fluorine Radioisotopes | 2 | 2012 | 424 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 414 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 1998 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 9080 | 0.040 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 877 | 0.040 |
Why?
|
Disease Progression | 5 | 2012 | 13674 | 0.040 |
Why?
|
Colorectal Neoplasms | 2 | 2015 | 6982 | 0.040 |
Why?
|
Young Adult | 8 | 2018 | 60131 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2000 | 498 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 4056 | 0.040 |
Why?
|
Incidental Findings | 2 | 2012 | 697 | 0.040 |
Why?
|
Electrophysiology | 1 | 2000 | 1266 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2000 | 413 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2600 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5434 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 385 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2002 | 1165 | 0.030 |
Why?
|
Mutation | 3 | 2019 | 30266 | 0.030 |
Why?
|
Radioisotopes | 1 | 2018 | 517 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2002 | 4978 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5196 | 0.030 |
Why?
|
Sulfonamides | 2 | 2018 | 1981 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 592 | 0.030 |
Why?
|
United States | 3 | 2018 | 73186 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 123 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2000 | 799 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2018 | 583 | 0.030 |
Why?
|
Filgrastim | 1 | 2014 | 131 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4919 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 428 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 823 | 0.030 |
Why?
|
Mesenchymoma | 1 | 2014 | 50 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 41808 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4545 | 0.030 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 100 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8559 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2008 | 916 | 0.030 |
Why?
|
Movement | 1 | 2000 | 1490 | 0.030 |
Why?
|
Cholecystitis, Acute | 1 | 2013 | 81 | 0.030 |
Why?
|
Walking | 1 | 2000 | 1201 | 0.030 |
Why?
|
Acute Disease | 2 | 2013 | 7245 | 0.030 |
Why?
|
World Health Organization | 1 | 2018 | 1328 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 549 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7957 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1089 | 0.020 |
Why?
|
Fibromatosis, Abdominal | 1 | 2011 | 21 | 0.020 |
Why?
|
Renal Veins | 1 | 2012 | 103 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.020 |
Why?
|
Gallbladder | 1 | 2013 | 308 | 0.020 |
Why?
|
Pancreas | 1 | 2018 | 1700 | 0.020 |
Why?
|
Viscera | 1 | 2012 | 138 | 0.020 |
Why?
|
Sclerosis | 1 | 2012 | 212 | 0.020 |
Why?
|
Carcinosarcoma | 1 | 2012 | 108 | 0.020 |
Why?
|
Endonucleases | 1 | 2014 | 371 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2012 | 2433 | 0.020 |
Why?
|
Buttocks | 1 | 2011 | 111 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2013 | 409 | 0.020 |
Why?
|
Echocardiography | 2 | 2015 | 5047 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2017 | 997 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1748 | 0.020 |
Why?
|
Joints | 1 | 2012 | 324 | 0.020 |
Why?
|
Gastroenteritis | 1 | 2012 | 235 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2012 | 348 | 0.020 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2011 | 128 | 0.020 |
Why?
|
Ovariectomy | 1 | 2012 | 613 | 0.020 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2012 | 249 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1620 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11116 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8055 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12562 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2408 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 737 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11230 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1197 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2013 | 584 | 0.020 |
Why?
|
Leiomyosarcoma | 1 | 2012 | 425 | 0.020 |
Why?
|
Esophagectomy | 1 | 2012 | 482 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1661 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 947 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2009 | 160 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1629 | 0.020 |
Why?
|
Adolescent | 5 | 2012 | 89244 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1723 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2234 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1194 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 7148 | 0.020 |
Why?
|
Medical Records | 1 | 2012 | 1411 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 866 | 0.020 |
Why?
|
Nephrectomy | 1 | 2012 | 949 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1141 | 0.020 |
Why?
|
Prednisone | 1 | 2011 | 1567 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1447 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 173 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1836 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4862 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2945 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10765 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 810 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2590 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2664 | 0.020 |
Why?
|
Ulnar Nerve | 1 | 2005 | 104 | 0.010 |
Why?
|
Ischemia | 1 | 2013 | 1900 | 0.010 |
Why?
|
Median Nerve | 1 | 2005 | 133 | 0.010 |
Why?
|
Child | 4 | 2012 | 80960 | 0.010 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 878 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6512 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1060 | 0.010 |
Why?
|
Aging | 1 | 2002 | 8745 | 0.010 |
Why?
|
Outpatients | 1 | 2011 | 1603 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2280 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2011 | 1682 | 0.010 |
Why?
|
Child, Preschool | 2 | 2008 | 42683 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6805 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3644 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2875 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2167 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7578 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39394 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1437 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3463 | 0.010 |
Why?
|
Hindlimb | 1 | 2002 | 516 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3532 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1769 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12095 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4207 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4790 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6888 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4447 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5891 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54962 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2268 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9618 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7460 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74976 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4756 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14794 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11684 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4879 | 0.010 |
Why?
|
Lung | 1 | 2012 | 10099 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23653 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21547 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10868 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4628 | 0.010 |
Why?
|
Heart Failure | 1 | 2015 | 11879 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 13048 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18435 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21188 | 0.010 |
Why?
|
Brain | 1 | 2012 | 27453 | 0.000 |
Why?
|
Mice | 1 | 2002 | 82072 | 0.000 |
Why?
|
Animals | 1 | 2002 | 169335 | 0.000 |
Why?
|